KEGG pathway enrichment analysis via Metascape (p < 0.01) revealed that SJGS exerted hypolipidemic effects by modulating PPAR, AMPK, PI3K-Akt, lipid metabolism, and non-alcoholic fatty liver disease pathways. The gene discussed is AKT1; the disease is alcoholic fatty liver disease.